Open Interest and Volume Dynamics
The latest data reveals that Lupin’s open interest in derivatives rose sharply by 3,109 contracts, a 12.06% increase from the previous figure of 25,786 to 28,895. This surge in OI is accompanied by a robust volume of 38,632 contracts traded, underscoring heightened trading activity. The futures segment alone accounted for a value of approximately ₹56,707.56 lakhs, while options contributed an astronomical ₹33,598.11 crores, culminating in a total derivatives value of ₹60,257.23 lakhs. Such figures indicate strong investor interest and suggest that market participants are positioning themselves strategically ahead of anticipated price movements.
Price Performance and Technical Indicators
Lupin’s stock price has demonstrated resilience and strength, touching an intraday high of Rs 2,381, marking a 3.17% gain on the day. This performance outpaced the Pharmaceuticals & Biotechnology sector’s 1.80% rise and contrasted with the broader Sensex’s decline of 0.64%. Notably, Lupin has reversed its short-term downtrend after two consecutive days of losses, signalling a potential trend reversal. The stock is trading comfortably above its key moving averages – 5-day, 20-day, 50-day, 100-day, and 200-day – which collectively reinforce a bullish technical setup.
Investor Participation and Liquidity
Investor engagement has also intensified, with delivery volumes on 22 Apr reaching 6.31 lakh shares, a significant 27.81% increase over the five-day average delivery volume. This rise in delivery volume suggests that investors are not merely trading for short-term gains but are increasingly holding positions, reflecting confidence in Lupin’s medium to long-term prospects. Furthermore, the stock’s liquidity remains robust, with the capacity to handle trade sizes of up to ₹4.02 crores based on 2% of the five-day average traded value, making it an attractive option for institutional and retail investors alike.
Just announced: This Small Cap from Tyres & Allied with precise target price is our pick for the week. Get the pre-market insights that informed this selection!
- - Just announced pick
- - Pre-market insights shared
- - Tyres & Allied weekly focus
Market Positioning and Directional Bets
The surge in open interest alongside rising volumes typically signals that traders are taking fresh positions rather than merely closing existing ones. In Lupin’s case, the 12.06% increase in OI suggests that market participants are building bullish bets, anticipating further upside. This is corroborated by the stock’s recent price action, which includes a breakout to a new 52-week high and sustained trading above all major moving averages.
Options market data further supports this bullish sentiment. The substantial options value of over ₹33,598 crores indicates active hedging and speculative activity, with traders likely favouring call options to capitalise on expected price appreciation. The futures market’s sizeable value of ₹56,707.56 lakhs also points to strong directional interest, with participants possibly leveraging futures contracts to amplify gains.
Mojo Score and Analyst Ratings
Lupin currently holds a Mojo Score of 74.0, categorised as a ‘Buy’ grade. This represents a slight downgrade from its previous ‘Strong Buy’ rating assigned on 21 Apr 2026, reflecting a cautious but positive outlook. The mid-cap pharmaceutical company’s market capitalisation stands at ₹1,07,570 crores, underscoring its significant presence in the sector. Despite the minor rating adjustment, Lupin’s fundamentals and technicals remain robust, supported by strong investor participation and favourable market conditions.
Sector and Broader Market Context
Within the Pharmaceuticals & Biotechnology sector, Lupin’s outperformance by 0.35% relative to peers highlights its relative strength. The sector itself has been buoyed by ongoing demand for innovative therapies and a resilient domestic and export market. Meanwhile, the broader Sensex’s decline of 0.64% on the same day emphasises Lupin’s defensive qualities and appeal as a growth-oriented stock amid market volatility.
Want to dive deeper on Lupin Ltd.? There's a real-time research report diving right into the fundamentals, valuations, peer comparison, financials, technicals and much more!
- - Real-time research report
- - Complete fundamental analysis
- - Peer comparison included
Outlook and Investor Considerations
Given the current market signals, Lupin appears well-positioned for further gains in the near term. The combination of rising open interest, strong volume, and positive price momentum suggests that investors are increasingly confident in the stock’s prospects. However, the slight downgrade from ‘Strong Buy’ to ‘Buy’ indicates that some caution is warranted, possibly due to valuation considerations or broader market uncertainties.
Investors should monitor Lupin’s price action closely, particularly its ability to sustain levels above the recent 52-week high of Rs 2,381. Additionally, tracking changes in open interest and volume in the derivatives market will provide valuable insights into evolving market sentiment and potential shifts in positioning.
Overall, Lupin’s robust fundamentals, coupled with encouraging technical and derivatives market indicators, make it a compelling candidate for investors seeking exposure to the Pharmaceuticals & Biotechnology sector’s growth trajectory.
Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today
